PolyPeptide Group AG PPGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CHF 31.60
- Day Range
- CHF 31.30–32.15
- 52-Week Range
- CHF 14.11–35.80
- Bid/Ask
- CHF 31.00 / CHF 31.70
- Market Cap
- CHF 1.05 Bil
- Volume/Avg
- 19,653 / 26,408
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.34
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,277
- Website
- https://www.polypeptide.com
Comparables
Valuation
|
Metric
|
PPGN
|
BANB
|
DESN
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 46.35 | 45.07 |
Price/Book Value | 3.02 | 4.18 | 4.02 |
Price/Sales | 3.34 | 9.48 | 10.90 |
Price/Cash Flow | 70.61 | 18.01 | 34.75 |
Price/Earnings
PPGN
BANB
DESN
Financial Strength
|
Metric
|
PPGN
|
BANB
|
DESN
|
|---|---|---|---|
Quick Ratio | 1.09 | 1.57 | 1.57 |
Current Ratio | 1.85 | 3.41 | 2.56 |
Interest Coverage | −9.37 | 4,655.00 | 95.01 |
Quick Ratio
PPGN
BANB
DESN
Profitability
|
Metric
|
PPGN
|
BANB
|
DESN
|
|---|---|---|---|
Return on Assets (Normalized) | −4.24% | 7.25% | 7.10% |
Return on Equity (Normalized) | −7.32% | 9.18% | 9.59% |
Return on Invested Capital (Normalized) | −5.69% | 9.02% | 8.43% |
Return on Assets
PPGN
BANB
DESN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hvrbqrnjx | Gzwb | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Kvztxlbkn | Qhbcdk | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Xxstghdy | Msvp | $48.4 Bil | |||
| Viatris Inc
VTRS
| Ydsbfcmmh | Mkvw | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Ccyqttvh | Vwtbd | $13.5 Bil | |||
| Catalent Inc
CTLT
| Nhpmytfsg | Zkxwxf | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Ldpblcnk | Cplgvyt | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Nfggqktv | Cdvx | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Rwpxlnfy | Xjsmt | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Nsgnnxw | Sbsby | $2.3 Bil |
United States